Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tuberculosis vaccines comprising antigens expressed during the latent infection phase

Tuberculosis vaccines comprising antigens expressed during the latent infection phase

US Patent 8101193 · Granted Jan 24, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnostic reagents for improved in vivo or in vitro cell-mediated immunological2020
M.tuberculosis vaccines2018
M.tuberculosis vaccines2018
Vaccines comprising TB10.42017
Vaccines comprising TB10.42017
M. tuberculosis vaccines2016
M. tuberculosis vaccines2016
Tuberculosis vaccines comprising antigens expressed during the latent infection 2014
Tuberculosis vaccines comprising antigens expressed during the latent infection 2014
Vaccines comprising TB10.42013
Vaccines comprising TB10.42013
Tuberculosis vaccines comprising antigens expressed during the latent infection 2012